Last $21.82 USD
Change Today +0.38 / 1.77%
Volume 335.6K
ACAD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 12:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

acadia pharmaceuticals inc (ACAD) Key Developments

ACADIA Pharmaceuticals Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 01:30 PM

ACADIA Pharmaceuticals Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 01:30 PM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States.

ACADIA Pharmaceuticals Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 10:00 AM

ACADIA Pharmaceuticals Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-02-2014 10:00 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Uli Hacksell, Chief Executive Officer, President, Principal Financial Officer, Principal Accounting Officer and Director.

ACADIA Pharmaceuticals Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

ACADIA Pharmaceuticals reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the period, the company's loss was $0.19 basic and diluted per share, double a loss of $0.08 basic and diluted per share a year ago. Collaborative revenues were $30,000 against $417,000 a year ago. Loss from operations was $17,958,000 against $6,164,000 a year ago. Net loss was $17,828,000 against $6,123,000 a year ago.

ACADIA Pharmaceuticals Inc. to Report Q1, 2014 Results on May 06, 2014

ACADIA Pharmaceuticals Inc. announced that they will report Q1, 2014 results at 5:00 PM, Eastern Standard Time on May 06, 2014

ACADIA Pharmaceuticals Inc., Q1 2014 Earnings Call, May 06, 2014

ACADIA Pharmaceuticals Inc., Q1 2014 Earnings Call, May 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $21.82 USD +0.38

ACAD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ACAD.
View Industry Companies
 

Industry Analysis

ACAD

Industry Average

Valuation ACAD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2,629.6x
Price/Book 5.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2,312.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.